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 We describe two cases of multiple carcinoids and hyperplasia, 
dysplasia and neoplasia of enterochromaffin-like (ECL) cells 
associated with atrophic gastritis type A in the stomach. 
Multiple polypoid lesions measuring 1 cm showed upper 
gastroendoscopic features. They were all found in the upper 
body of the stomach. All polypoid lesions with carcinoid foci 
were observed from the deeper layers of the propria mucosa 
to the submucosa and were surrounded by ECL cells. In one 
case, the serum gastrin level which was as high as 1700 
pg/mi, returned to normal range (17 pg/ml) after gastrectomy. 
It is suggested that longstanding hypergastrinemia may have 
played a causative role in the development of multiple gas-
tric carcinoid tumors. A total gastrectomy was considered 
essential for treatment of aggressive multiple carcinoid tu-
mors with hypergastrinemia. 
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hindgutl'. Foregut carcinoids, encompassing bronchial, 
gastric, and duodenal carcinoids, may cause an atypical 
carcinoid syndrome with severe generalized flush, diarrhea, 
cutaneous edema, lacrimation, and bronchoconstriction. 
Three main variants of human gastric carcinoid tu-
mors have been identified: types 1, 2 and 32-8'. Type 1 
gastric carcinoids originate from the mucosal ECL 
cells which can synthesize and store histamine. These 
tumors are localized to the fundus, are mainly multi-
ple, and are associated with type A gastritis. The 
pathogenesis of these tumors is claimed to be the 
trophic effect of the hypergastrinemia on the ECL 
cells in the fundus9-11'. Gastric carcinoid tumors associ-
ated with gastritis type A are usually small (less than 
1 cm), may be single or multiple, and rarely progress 
to metastatic disease1214'. We report here on two cases 
of gastritis type A with multiple carcinoid tumors 




 Carcinoid tumors are traditionally divided into endo-
crine growths originating from foregut, midgut and
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 Patient 1 was a 51 year old male who had been di-
agnosed with diabetes mellitus 11 years ago and had 
lost 20 kg of weight during the last 2 months. Gastric 
endoscopy confirmed multiple 1 cm gastric polyps 
within the body of the stomach. Histological examina-
tion of the gastric mucosal biopsies of the corpus and 
fundus showed atrophic gastritis with focal intestinal 
metaplasia. Biopsies of the gastric polyps were consis-
tent with the multiple carcinoid lesions in the body of
the stomach. Laboratory data are shown in Table 1. 
Total gastrectomy was performed because gastric 
carcinoid tumors showed infiltrative growth of ECL 
cells to the submucosa and lymph vessel invasion. In 
the corpus and fundus a total of 36 carcinoid lesions 
were found, ranging in size from 0.1 to 8.0 mm.
Table 1. Laboratory results of Cases 1 and 2.
Laboratory results Case 1 Case 2 
WBC 7200/mm' 2770/mm' 
RBC 386mm3 288mm3 
Hb 11.5g/dl 9.7g/d/ 
Ht 33.8% 26.2% 
Plate 28.0x 104/mm3 15.0x 104/mm3 
Parietal cell antibody (+) ND 
LDH 161 lU/l 456 lU/1 
Gastrin 1700pg/ml ND 
Serotonin 66ng/ml ND 
Urine5-HIAA 1.9mg/day ND 
CEA ND 2.2mg/ml 
CA15-3 ND 17 U/ml
ND; not done
Patient 2
 Patient 2 was a 50 year old female who had a mas-
tectomy for stage IIIa left breast cancer. Six months 
later she complained of epigastric discomfort. Gastric 
examination showedmultiple gastric polyps in the body 
of the stomach. Biopsies suspected poorly differentiated 
adenocarcinoma in the body of the stomach. Multiple 
carcinoid tumors were confirmed in histological and 
immunohistochemical studies following total gastrectomy. 
Thirty-one multiple carcinoid lesions ranging in size 
from 0.1 to 7.4 mm were found focal histologicaly in-
vestigated specimens of the stomach.
Material and Methods
 The resected stomachs were fixed in 10% neutral 
buffered formalin and then examined in serial cross-
sections. The tissue blocks were dehydrated and rou-
tinely embedded in paraffin. Sections of 3-micron
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thickness were cut and stained with hematoxylin and 
eosin, Periodic acid-Schiff (PAS) and Grimelius and 
Fontana-Masson stains. 
 For immunohistochemistry, the standard avidin-biotin-
peroxidase immune complex method was employed with 
a Vectastain ABC Kit (Vector Laboratories, Burlingame, 
CA) on the formalin fixed and paraffin embedded tissue 
sections. Immunohistochemical staining was performed 
using antibodies against the following: Chromogranin A, 
gastrin, serotonin, somatostatin, and synaptophisin.
Morphological examination
 In both cases the fundic regions showed an atrophic 
change associated with a proliferation of mucous cells 
and moderate degree of intestinal metaplasia. ECL 
cells separated from the atrophic fundic glands or 
carcinoids were detected in the deep lamina propria, 
muscularis mucosa, or submucosa of the fundic re-
gions showing the atrophic changes. A total of sixty-
seven lesions of ECL cell hyperplasia or Endocrine cell 
micronest (ECM) and distinct microcarcinoids, ranging 
in size from 0.1 to 8.0 mm in size (36 in Case 1 and 
31 in Case 2) were detected. 
 Of the 36 lesions in Case 1 of the ECL cells and 
microcarcinoids measuring from 0.1 to 8.0 mm in di-
ameter (average 1.4 mm), there were 25 lesions from 
0.1 to 8.0 mm (average 1.7 mm) in the mucosa, and 11 
lesions from 0.1 to 6.0 mm (average 1.0 mm) in the 
submucosa. 
 In Case 2, the 31 lesions of the ECL cells and 
microcarcinoids measuring from 0.1 to 7.4 mm in di-
ameter (average 0.94 mm) were found only in the 
mucosa of the stomach corpus. 
 Morphologically, of the 36 ECL or ECM and carcinoids, 
14 (39%) showed trabecular or ribbon-like structures 
(Fig. 1A) and 22 (61%) had solid, anastomosing trabecular, 
ribbon-like, glandular and/or acinar structures with 
fibrovascular stroma (Fig. 1B). There were various de-
grees of large cells with large atypical nuclei, which were 
about twice the size of lymphocyte nuclei. Carcinoid tu-
mors showed an expansive growth and a conspicuous 
infiltration into the muscularis mucosae and submucosa. 
They often showed a perivascular arrangement and 
focal infiltration of lymphatic vessels. 
 In both cases all carcinoid tumors were positive for 
argyrophil and argentaffin with Grimelius and Fontana-
Masson silver stains.
Immunohistochemistry
 The immunohistochemical findings of carcinoid tu-
mors are summarized in Table 2. All carcinoid lesions
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showed diffuse positivity for Chromogranin A (Fig. 
2A). In the antral region, there was a diffuse intra-
glandular increase in the number of gastrin positive 
cells in the middle zone of the pyloric glands (Fig. 2B). 
Synaptophisin and serotonin were scattered positive 
in carcinoid tumors.
Figure 1. (A) Carcinoid tumors illustrating a trabecular or al-
veolar pattern with ribbon-like structures. Tumors are com-
prised of small, round cells with single and round-to-oval nu-
clei in case 1.
Figure 2. (A) Hyperplastic chromogranin A-positive endo-
crine cells from lines in a focus of mucous neck hyperplasia 
and numerous micronodules in the deep lamina propria.
Figure 1. (B) Carcinoid showing an expansive growth and 
solid, anastomosing trabecular structure with a fibrovascular 
stroma, composed of large, atypical cells intermingled with 
small cells in case 2 (H&E; A, magnification x80; B, mag-
nification x80).
Table 2. Immunohistochemical results on carcinoid tumors
Immunohistochemical results Case 1 Case 2 
Chromogranin A + + 
Neuron-specific enolase + + 
Gastrin - -
Serotonin + + 
Somatostatin + -
Synaptophism + +
Figure 2. (B) Proliferation of gastrin positive cells in the 
antral region. Scattered gastrin positive cells are present 
even in the foveolar epithelium (A, magnification x80; B, 
magnification x80).
Discussion
 Gastric carcinoids compose only 0.3% of all gastric 
tumors and 2.2% of all carcinoid tumors"'. Gastric 
carcinoids are derived from ECL cells present in the 
body of the stomach"'. In patients with or without 
pernicious anemia, antral G cells secrete enormous 
quantities of gastrin in response to achlorhydria re-
sulting in proliferation of ECL cells" 16'1" The spectrum 
of these proliferative changes include hyperplasia,
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dysplasia, and neoplasia18'. 
 Although the preoperative clinical examinations in-
dicated hypergastrinemia in the two cases presented 
here, the histological and immunohistochemical find-
ings were consistent with the characteristics of gastric 
carcinoid tumors comprised of argyrophilic cells. In 
the rat, hypergastrinemia by itself has been reported 
to stimulate the development of gastric argyrophilic 
or ECL cell carcinoid tumors"'. However, in patients 
with Zollinger-Ellison syndrome (ZES), hypergastrinemia 
simply leads to a proliferation of argyrophilic or ECL 
cells within the confines of the fundic mucosa20'. In the 
current cases, there was no history of diarrhea, symp-
toms of carcinoid syndrome and ZES, evidence of mul-
tiple endocrine neoplasia type 1 (MEN-1), or pernicious 
anemia. 
 Autoimmune diseases such as hypothyroidism and 
diabetes mellitus may coexist with gastric multiple 
carcinoid tumors. Clinical management is still undefined"'. 
In the current study, ECL cell hyperplasia or ECM 
nodules were localized in the lower third of the 
mucosa and showed scattered staining for the hor-
mone serotonin but none for gastrin. However, in the 
25 carcinoid lesions observed in this study, each 
carcinoid was accompanied by a large number of pe-
Case 1. Total gastrectomy
ripheral ECL cells or ECM, which usually were pre-
sent adjacent to proliferating argyrophilic cells in 
multifocal pyloric gland metaplasia of atrophic gastri-
tis. Thus, the origin and development of multiple gas-
tric carcinoid tumors and ECM may be due to the 
proliferating argyrophilic cells in multifocal pyloric 
gland metaplasia, which in turn is caused by atrophic 
gastritis as well as to the trophic action of excess 
gastrin in the serum. 
 The finding of diffuse ECL cell hyperplasia or ECM 
within pseudopyloric metaplasia in gastric biopsies 
from fundus mucosa is a characteristic reported only 
for carcinoids with atrophic gastritis type A. In this 
study, the size of carcinoid tumors was less than 1 cm 
with focal lymph vessel invasion and scattered tumor 
infiltration of the mucosa and submucosa. Though it 
may be possible to misinterpet lymphatic invasion, 
true invasion of lymph vessels can be clearly distin-
guished by reticulin fibers between argyrophil cells 
that are continuous with reticulin fibers of surround-
ing tissue"'. The ECL cell hyperplasia or ECM may fi-
nally expand to larger, infiltrating neoplasms with a 
significant risk of metastases"'. Carcinoid tumors 
measuring less than 1 cm in diameter apparently bear 
only a very low risk of metastases and can be re-
moved by polypectomy or circumscribed local exci-
sion. Subsequent endoscopic follow-up of these pa-
tients has been recommended. Large carcinoid tumors 
may require local excision and antrectomy, whereas 
invasive tumors may need a total gastrectomy2s-25'. 
Therefore, clinicians caring for patients with atrophic 
gastritis type A and hypergastrinemia must remain 
aware of the potential for the development of gastric 
carcinoid tumors.
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